113 related articles for article (PubMed ID: 2897375)
1. Analysis of esmolol in human blood by high-performance liquid chromatography and its application to pharmacokinetic studies.
Achari R; Drissel D; Thomas D; Shin K; Look Z
J Chromatogr; 1988 Feb; 424(2):430-4. PubMed ID: 2897375
[No Abstract] [Full Text] [Related]
2. Simple and rapid high-performance liquid chromatographic assay for esmolol.
Fan CD; Zhao H; Chow MS
J Chromatogr; 1991 Sep; 570(1):217-23. PubMed ID: 1686774
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias.
Adamson PC; Rhodes LA; Saul JP; Dick M; Epstein MR; Moate P; Boston R; Schreiner MS
Pediatr Cardiol; 2006; 27(4):420-7. PubMed ID: 16835806
[TBL] [Abstract][Full Text] [Related]
4. Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study.
Rathod R; Prasad LP; Rani S; Nivsarkar M; Padh H
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):219-23. PubMed ID: 17702675
[TBL] [Abstract][Full Text] [Related]
5. Validated HPLC method for quantitative determination of talinolol in rat plasma and application to a preclinical pharmacokinetic study.
Pathak SM; Musmade PB; Bhat KM; Udupa N
Bioanalysis; 2010 Jan; 2(1):95-104. PubMed ID: 21083123
[TBL] [Abstract][Full Text] [Related]
6. Determination of the beta-adrenoceptor blocking drug B24/76 in serum by high-performance liquid chromatography with fluorimetric detection after pre-column dansylation.
Zschiesche M; Baumann A
J Chromatogr; 1989 Mar; 488(2):482-6. PubMed ID: 2568366
[No Abstract] [Full Text] [Related]
7. Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties.
Volz-Zang C; Eckrich B; Jahn P; Schneidrowski B; Schulte B; Palm D
Eur J Clin Pharmacol; 1994; 46(5):399-404. PubMed ID: 7957532
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic method for the determination of carazolol in serum or plasma of pigs.
Kadir F; Zuidema J
J Chromatogr; 1990 May; 527(2):461-6. PubMed ID: 1974898
[No Abstract] [Full Text] [Related]
9. High-performance liquid chromatographic assay for the major blood metabolite of esmolol--an ultra short acting beta blocker.
Stampfli HF; Lai CM; Yacobi A; Sum CY
J Chromatogr; 1984 Jul; 309(1):203-8. PubMed ID: 6148350
[No Abstract] [Full Text] [Related]
10. Esmolol-digoxin drug interaction.
Lowenthal DT; Porter RS; Achari R; Turlapaty P; Laddu AR; Matier WL
J Clin Pharmacol; 1987 Aug; 27(8):561-6. PubMed ID: 2888792
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of (R)- and (S)-celiprolol in human plasma and urine: high-performance liquid chromatographic assay on a chiral stationary phase with fluorimetric detection.
Hartmann C; Krauss D; Spahn H; Mutschler E
J Chromatogr; 1989 Nov; 496(2):387-96. PubMed ID: 2575621
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic method for determination of ronactolol in urine and plasma: evaluation of pharmacokinetic parameters in healthy humans.
Mannucci C; Caviglioli G; Perico A; Triolo A
J Pharm Sci; 1992 Jun; 81(6):556-8. PubMed ID: 1355791
[TBL] [Abstract][Full Text] [Related]
13. Effects of esmolol on cardiac function: evaluation by noninvasive techniques.
Iskandrian AS; Hakki AH; Laddu A
Am J Cardiol; 1985 Oct; 56(11):27F-32F. PubMed ID: 2864845
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of esmolol in children.
Wiest DB; Trippel DL; Gillette PC; Garner SS
Clin Pharmacol Ther; 1991 Jun; 49(6):618-23. PubMed ID: 1676357
[TBL] [Abstract][Full Text] [Related]
15. Quantification of carvedilol in human plasma by liquid chromatography using fluorescence detection: application in pharmacokinetic studies.
Zarghi A; Foroutan SM; Shafaati A; Khoddam A
J Pharm Biomed Anal; 2007 May; 44(1):250-3. PubMed ID: 17391893
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of the enantiomers of esmolol and its acid metabolite in human plasma by reversed phase liquid chromatography with solid-phase extraction.
Tang YH; He Y; Yao TW; Zeng S
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):249-54. PubMed ID: 15135097
[TBL] [Abstract][Full Text] [Related]
17. Effect of hypothermia and sampling site on blood esmolol concentrations.
Jacobs JR; Croughwell ND; Goodman DK; White WD; Reves JG
J Clin Pharmacol; 1993 Apr; 33(4):360-5. PubMed ID: 8097210
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs.
Arsenault WG; Boothe DM; Gordon SG; Miller MW; Chalkley JR; Petrikovics I
Am J Vet Res; 2005 Dec; 66(12):2172-6. PubMed ID: 16379664
[TBL] [Abstract][Full Text] [Related]
19. Esmolol during cardiopulmonary bypass.
Abramson DC; Pivalizza EG; Mehlhorn U
Anesth Analg; 1995 Aug; 81(2):429-30. PubMed ID: 7618750
[No Abstract] [Full Text] [Related]
20. Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration.
Gianesello V; Brenn E; Figini G; Gazzaniga A
J Chromatogr; 1989 Jul; 473(2):343-52. PubMed ID: 2570078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
